Enduring Materials

Access slide decks and video via the links in the schedule below.

PDF = PDF of slides is available

= Presentation video is available

Program Schedule Thursday, November 10, 2016
8:00 a.m. – 8:10 a.m.	Welcome & Introductions Margaret K. Callahan, MD, PhD – Memorial Sloan Kettering Cancer Center
Session I: Basic Immunology – A Brief Overview 2 AMA PRA Category 1 Credits™
8:10 a.m. – 8:45 a.m.	Introduction to Innate Immunity Miriam Merad, MD, PhD – Icahn School of Medicine at Mount Sinai
8:45 a.m. – 9:20 a.m.	Overview of Adaptive Immunity Jonathan Powell, MD, PhD – Johns Hopkins University
9:20 a.m. – 9:55 a.m.	Obstacles to Driving an Immune Response Nicholas Arpaia, PhD – Columbia University Medical Center
9:55 a.m. – 10:10 a.m.	Panel Questions & Answers
Session II: Treating Tumors with Passive Immunotherapy 2 AMA PRA Category 1 Credits™
10:25 a.m. – 10:30 a.m.	Session II Introduction Margaret K. Callahan, MD, PhD – Memorial Sloan Kettering Cancer Center
10:30 a.m. – 11:05 a.m.	Adoptive T Cell Therapy Saar I. Gill, MD – University of Pennsylvania
11:05 a.m. – 11:40 a.m.	Monoclonal Antibodies and Bi-Specifics/Structure and Mechanism of Action Charles G. Drake, MD, PhD – Columbia University Herbert Irving Comprehensive Cancer Center
11:40 a.m. – 12:15 p.m.	Cytokines: Interferons, Interleukins and Beyond Michael Atkins, MD – Georgetown-Lombardi Comprehensive Cancer Center
12:15 p.m. – 12:30 p.m.	Panel Questions & Answers
Session III: Active Immunotherapy – Unleashing the Patient’s Own Immune System 1.5 AMA PRA Category 1 Credits™
1:30 p.m. – 1:35 p.m.	Session III Introduction Nina Bhardwaj, MD, PhD – The Tisch Cancer Institute at The Mount Sinai Medical Center
1:35 p.m. – 2:10 p.m.	Cancer Vaccines Patrick Ott, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School
2:10 p.m. – 2:45 p.m.	Targeting Regulatory Molecules in Cancer Therapy: New Insights and Opportunities Casey Ager – University of Texas MD Anderson Cancer Center
2:45 p.m. – 3:00 p.m.	Panel Questions & Answers
Session IV: Figuring out How it All Works and Future Directions 1.75 AMA PRA Category 1 Credits™
3:15 p.m. – 3:20 p.m.	Session IV Introduction Nina Bhardwaj, MD, PhD – The Tisch Cancer Institute at The Mount Sinai Medical Center
3:20 p.m. – 3:55 p.m.	Immune Monitoring and Next Generation Sacha Gnjatic, PhD – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
3:55 p.m. – 4:30 p.m.	Single-Cell Analysis of Tumor Infiltrating T Cell in Human Colorectal Cancer Arnold Han, MD, PhD – Columbia University Medical Center
4:30 p.m. – 4:45 p.m.	Panel Questions and Answers
4:45 p.m. – 5:00 p.m.	Closing Remarks Nina Bhardwaj, MD, PhD – The Tisch Cancer Institute at the Mount Sinai Medical Center